Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial

Kasper K Iversen, Børge Teisner, Per Winkel, Christian Gluud, Erik Kjøller, Hans Jørn Kolmos, Per Rossen Hildebrandt, Jørgen Hilden, Jens Kastrup, CLARICOR Trial Group

39 Citationer (Scopus)

Abstract

Pregnancy associated plasma protein-A (PAPP-A) is a potential new marker for vulnerable plaques in the coronary arteries only examined in stable coronary disease (CAD) in patients undergoing coronary angiography. Here we address the prognostic value of serum PAPP-A in unselected stable CAD patients.
OriginalsprogEngelsk
TidsskriftAtherosclerosis
Vol/bind214
Udgave nummer1
Sider (fra-til)203-8
Antal sider6
ISSN0021-9150
DOI
StatusUdgivet - 1 jan. 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Pregnancy associated plasma protein-A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater